Research
Compare
Two to six companies, their latest annual figures side by side, from SEC filings.
BEAMBeam Therapeutics Inc.
| Figure | BEAMBeam Therapeutics Inc.FY2025 · Dec |
|---|---|
| Revenue | $139.74M |
| Revenue, yoy | +120.0% |
| Net income | $79.99M |
| Net income, yoy | +78.8% |
| Net margin | -57.2% |
| Free cash flow | $360.05M |
| FCF margin | -257.7% |
| EPS, diluted | $0.81 |
Add another company.
Annual · FY2021–FY2025 · USD
From SEC EDGARSame fiscal periods, as filed